Staggered botulinum toxin-a injections into parotid and submandibular glands prior to four-duct ligation for pediatric sialorrhea

被引:0
|
作者
Calim, Omer Faruk [1 ,2 ]
Polat, Emre [2 ]
Ozturan, Orhan [2 ]
机构
[1] Istanbul Medipol Univ, Fac Med, Dept Otorhinolaryngol, Goztepe Mah Ataturk Cad 40-16, TR-34815 Istanbul, Turkiye
[2] Bezmialem Vakif Univ, Fac Med, Dept Otorhinolaryngol, Istanbul, Turkiye
关键词
Sialorrhea; Drooling; Treatment; Botulinum toxin; Four-duct ligation; CEREBRAL-PALSY; CHILDREN; PREVALENCE;
D O I
10.1007/s00405-024-09022-z
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
ObjectivesThis study aimed to assess the effectiveness of four-duct ligation following Botulinum toxin-A injections into the parotid and submandibular glands in pediatric patients with sialorrhea resistant to nonsurgical treatments. Prior research has individually explored either surgical or Botulinum toxin interventions; however, the safety and efficacy of the combined approach to these treatments have yet to be documented.MethodsPatients were assessed before surgery and 6, 12, and 24 months post-operatively. Evaluations involved interviews with parents and caregivers, conducted face-to-face or by telephone, using the Drooling Severity and Frequency Scales. Additionally, metrics such as the daily count of bib changes and the hourly frequency of saliva wiping were recorded. Quality-of-life assessments were performed before and after the surgical procedures. All complications associated with the interventions were carefully recorded.ResultsThe study group consisted of 25 participants, with a median age of 6 years (range 2-17 years). Each participant was diagnosed with a neurological, metabolic, or genetic disorder. Evaluations were conducted periodically, culminating in a final follow-up at 24 months. The treatment demonstrated a 100% success rate at six months post-operation (25/25 patients), which slightly decreased to 96% at the 12-month mark (24/25 patients) and further to 84% by the 24-month follow-up (21/25 patients). Major complications were not observed. However, minor complications were reported in six patients (24%): three exhibited temporary facial swelling (12%), two encountered minor bleeding (8%), and one experienced excessive dryness (4%).ConclusionsThe combination of Botulinum toxin-A injection 3 weeks prior to the four-duct ligation procedure demonstrated high success rates and substantially reduced the incidence of infectious and cosmetic complications. Consequently, this staggered approach to combination treatment is recommended for managing pediatric sialorrhea cases that are resistant to non-surgical interventions.
引用
收藏
页码:2043 / 2051
页数:9
相关论文
共 5 条
  • [1] Sialorrhea in amyotrophic lateral sclerosis: A hypothesis of a new treatment - Botulinum toxin A injections of the parotid glands
    Bushara, KO
    MEDICAL HYPOTHESES, 1997, 48 (04) : 337 - 339
  • [2] Pediatric Sialorrhea: Submandibular Duct Rerouting and Intraparotid Botulinum Toxin A Injection With Literature Review
    Calim, Omer Faruk
    Hassouna, Hasan N. H.
    Yildirim, Yavuz Selim
    Dogan, Remzi
    Ozturan, Orhan
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2019, 128 (02): : 104 - 112
  • [3] Volumetric Studies of Submandibular and Parotid Glands May be Used as Indicators of Efficacy of Intraglandular Botulinum Toxin Type A Injections for Refractory Sialorrhea in Neurologically-Impaired Pediatric Patients
    Benko, W.
    Trapeni, J.
    McClain, M.
    Tibbett, A.
    Drake, M.
    ANNALS OF NEUROLOGY, 2016, 80 : S358 - S359
  • [4] Treatment of sialorrhoea with repeated ultrasound-guided injections of botulinum toxin A into the parotid and submandibular glands
    Taib, B. G.
    Williams, S. P.
    Sood, S.
    Ung, K.
    Nixon, P. P.
    Sharma, R.
    BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2019, 57 (05): : 442 - 448
  • [5] Safe and efficacious treatment of sialorrhea related to Parkinson's disease, parkinsonism and other neurological diseases with blind single transdermical botulinum toxin injections into the parotid glands: Clinical experience with 58 patients
    De Fabregues, O.
    Ribera, G.
    Coll, D.
    Martinez, J.
    Canovas, D.
    Viguera, M.
    Marco, M.
    Miquel, F.
    Gamez, J.
    MOVEMENT DISORDERS, 2007, 22 : S164 - S164